Clinical Trial Update: Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of ursodeoxycholic acid to reverse gastric intestinal metaplasia. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Intestinal Metaplasia

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Yongquan Shi | Conditions: Gastric Intestinal Metaplasia | Phase 4 | Status: RECRUITING